Funder
National Natural Science Foundation of China
Scientific Research Project of Hubei Provincial Department of Education
Undergraduate Training Program of Yangtze University for Innovation and Entrepreneurship
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Hepatitis C.
http://www.who.int/news-room/fact-sheets/detail/hepatitis-c
. Accessed 9 July 2019.
2. Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T. Toward a more accurate estimate of the prevalence of hepatitis c in the united states. Hepatology. 2015; 62(5):1353–63.
3. Surveillance for Viral Hepatitis-United States. 2016.
https://www.cdc.gov/hepatitis/statistics/2016surveillance/pdfs/2016HepSurveillanceRpt.pdf
. Accessed 11 Jan 2017.
4. Hope VD, Eramova I, Capurro D, Donoghoe MC. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect. 2014; 142(2):270–86.
5. Young J, Weis N, Hofer H, Irving W, Weiland O, Giostra E, Pascasio JM, Castells L, Prieto M, Postema R, et al.The effectiveness of daclatasvir based therapy in european patients with chronic hepatitis c and advanced liver disease. BMC Infect Dis. 2017; 17(1):45.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献